DeFloria Receives Investigational New Drug Application Clearance From FDA for Cannabinoid Drug to Treat Autism Spectrum Disorder
Marijuana Industry News February 25, 2025 MJ Shareholders
DeFloria plans to initiate a Phase 2 clinical trial by mid-year 2025.

MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers